Trottier S J, Veremakis C, O'Brien J, Auer A I
Department of Critical Care Medicine, St. John's Mercy Medical Center, St. Louis, MO.
Crit Care Med. 1995 Jan;23(1):52-9. doi: 10.1097/00003246-199501000-00011.
To determine the frequency of central venous catheter-induced deep vein thrombosis of the femoral vein.
Prospective, randomized, controlled trial.
Tertiary care center.
Forty-five patients in a medical-surgical intensive care unit who required central venous catheterization.
Patients were randomized to receive central venous catheterization in either upper (subclavian or internal jugular veins) or lower (femoral vein) catheterization sites. Lower extremity duplex ultrasound examinations were performed before central venous catheter placement, after removal of the catheter, and 7 days after catheter removal. Ultrasound examinations were reported as positive, nondiagnostic, or negative for deep vein thrombosis.
Of the 21 patients randomized to upper access sites, none developed positive or nondiagnostic duplex ultrasound examinations. Six (25%) of 24 patients randomized to the femoral access site developed lower extremity deep vein thrombosis (p = .02). In addition, seven (29%) patients randomized to the lower access site sustained non-diagnostic ultrasound examinations. A total of 13 (54%) of 24 patients from the lower access group developed abnormal ultrasound examinations (p < .001). Age, duration of catheterization, coagulation profile, deep vein thrombosis prophylaxis, and Acute Physiology and Chronic Health Evaluation II scores were similar between the upper and lower access groups.
Based on the data from this study, we concluded that femoral vein catheterization is associated with a 25% frequency of lower extremity deep vein thrombosis compared with similar patients receiving subclavian or internal jugular vein catheters. The femoral vein remains an important emergency venous access route. Physicians inserting femoral vein catheters should be aware of the risk of lower extremity deep vein thrombosis and should consider performing lower extremity duplex ultrasound examinations on removal of femoral vein catheters.
确定中心静脉导管所致股静脉深静脉血栓形成的发生率。
前瞻性、随机、对照试验。
三级医疗中心。
45例入住内科-外科重症监护病房且需要进行中心静脉置管的患者。
将患者随机分为两组,分别在上肢(锁骨下静脉或颈内静脉)或下肢(股静脉)置管部位进行中心静脉置管。在中心静脉导管置入前、导管拔除后以及拔除导管7天后进行下肢双功超声检查。超声检查结果报告为深静脉血栓形成阳性、无法诊断或阴性。
随机分配至上肢置管部位的21例患者中,无人出现双功超声检查阳性或无法诊断的情况。随机分配至股静脉置管部位的24例患者中有6例(25%)发生了下肢深静脉血栓形成(p = 0.02)。此外,随机分配至下肢置管部位的7例(29%)患者双功超声检查结果无法诊断。下肢置管组的24例患者中有13例(54%)超声检查结果异常(p < 0.001)。上肢和下肢置管组在年龄、置管持续时间、凝血指标、深静脉血栓形成预防措施以及急性生理与慢性健康状况评分系统II评分方面相似。
根据本研究数据,我们得出结论,与接受锁骨下静脉或颈内静脉置管的类似患者相比,股静脉置管导致下肢深静脉血栓形成的发生率为25%。股静脉仍是重要的紧急静脉通路。插入股静脉导管的医生应意识到下肢深静脉血栓形成的风险,并应考虑在拔除股静脉导管时进行下肢双功超声检查。